Abstract
Cordyceps, an entomopathogenic mushroom, is a famous traditional Chinese medicinal herb (TCM). This higher fungus contains various known and untapped bioactive metabolites, and is looked at as an important source of natural drugs while simultaneously provides good opportunities for discovering new drugs with immunomodulatory, antitumor, hypoglycemic and hypocholesterolemic functions. Therefore, the Cordyceps spp. has been receiving an increasing interest around the world as an interesting natural drug resource. Various secondary metabolites from Cordyceps fungi were reported to have antitumor activities, and antitumor mechanism of those bioactive compounds possesses multi-target, multi-level and multi-pathway characteristics. Challenges in investigations on Cordyceps fungi include the further elucidation of antitumor molecular mechanism and relationship between structure and function of their secondary metabolites.
Keywords: Cordyceps spp., secondary metabolite, antitumor, bioactivity, acting mechanism, Traditional Chinese Medicine (TCM)
Recent Patents on Biotechnology
Title: Secondary Metabolites from Cordyceps Species and Their Antitumor Activity Studies
Volume: 1 Issue: 2
Author(s): Jian-Hui Xiao and Jian-Jiang Zhong
Affiliation:
Keywords: Cordyceps spp., secondary metabolite, antitumor, bioactivity, acting mechanism, Traditional Chinese Medicine (TCM)
Abstract: Cordyceps, an entomopathogenic mushroom, is a famous traditional Chinese medicinal herb (TCM). This higher fungus contains various known and untapped bioactive metabolites, and is looked at as an important source of natural drugs while simultaneously provides good opportunities for discovering new drugs with immunomodulatory, antitumor, hypoglycemic and hypocholesterolemic functions. Therefore, the Cordyceps spp. has been receiving an increasing interest around the world as an interesting natural drug resource. Various secondary metabolites from Cordyceps fungi were reported to have antitumor activities, and antitumor mechanism of those bioactive compounds possesses multi-target, multi-level and multi-pathway characteristics. Challenges in investigations on Cordyceps fungi include the further elucidation of antitumor molecular mechanism and relationship between structure and function of their secondary metabolites.
Export Options
About this article
Cite this article as:
Xiao Jian-Hui and Zhong Jian-Jiang, Secondary Metabolites from Cordyceps Species and Their Antitumor Activity Studies, Recent Patents on Biotechnology 2007; 1 (2) . https://dx.doi.org/10.2174/187220807780809454
DOI https://dx.doi.org/10.2174/187220807780809454 |
Print ISSN 1872-2083 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4012 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Chemokine Receptors as Targets for Cancer Therapy
Current Pharmaceutical Design Advanced Diabetes Care: Three Levels of Prediction, Prevention & Personalized Treatment
Current Diabetes Reviews Uropathogenic Escherichia coli Mediated Urinary Tract Infection
Current Drug Targets Interrelationships Among Gut Microbiota and Host: Paradigms, Role in Neurodegenerative Diseases and Future Prospects
CNS & Neurological Disorders - Drug Targets Is Fibroblast Growth Factor Receptor 4 a Suitable Target of Cancer Therapy?
Current Pharmaceutical Design Anticancer and Cytotoxic Activities of [Cu(C6H16N2O2)2][Ni(CN)4] and [Cu(C6H16N2O2)Pd(CN)4] Cyanidometallate Compounds on HT29, HeLa, C6 and Vero Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Editorial (Thematic Issue: Bladder Conditions in Pediatric Patients: Genetics and Genomics)
Current Genomics Yttrium-90 – Current Status, Expected Availability and Applications of a High Beta Energy Emitter
Current Radiopharmaceuticals Vitamin D Represses the Aggressive Potential of Osteosarcoma
Endocrine, Metabolic & Immune Disorders - Drug Targets Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Pathogenesis and Treatment Options
Current Vascular Pharmacology Tumor Protein p63/microRNA Network in Epithelial Cancer Cells
Current Genomics Gold and Silver Nanoparticles for Applications in Theranostics
Current Topics in Medicinal Chemistry Identifying and Validating Oncology Therapeutic Targets in the Post- Genomics Era
Current Genomics Comprehensive Review of Cancer Chemopreventive Agents Evaluated in Experimental Carcinogenesis Models and Clinical Trials
Current Medicinal Chemistry 13-lncRNAs Signature to Improve Diagnostic and Prognostic Prediction of Hepatocellular Carcinoma
Combinatorial Chemistry & High Throughput Screening Therapeutic Potential of Group III Metabotropic Glutamate Receptors
Current Medicinal Chemistry Immunomodulation and Anti-inflammatory Roles of Polyphenols as Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Pharmacological Activities and Therapeutic Potential of Kaempferitrin in Medicine for the Treatment of Human Disorders: A Review of Medicinal Importance and Health Benefits
Cardiovascular & Hematological Disorders-Drug Targets Current Perspectives on Novel Drug Delivery Systems and Therapies for Management of Prostate Cancer: An Inclusive Review
Current Drug Targets Epothilones: From Discovery to Clinical Trials
Current Topics in Medicinal Chemistry